BDMD
Income statement / Annual
Last year (2025), Baird Medical Investment Holdings Limited's total revenue was $22.54 M,
a decrease of 39.15% from the previous year.
In 2025, Baird Medical Investment Holdings Limited's net income was -$27.28 M.
See Baird Medical Investment Holdings Limited,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$22.54 M |
$37.04 M |
$31.46 M |
$35.09 M |
$27.72 M |
$18.12 M |
$12.21 M |
| Cost of Revenue |
$3.65 M
|
$4.38 M
|
$4.23 M
|
$7.05 M
|
$4.54 M
|
$2.51 M
|
$1.30 M
|
| Gross Profit |
$18.88 M
|
$32.65 M
|
$27.23 M
|
$28.04 M
|
$23.18 M
|
$15.61 M
|
$10.91 M
|
| Gross Profit Ratio |
0.84
|
0.88
|
0.87
|
0.8
|
0.84
|
0.86
|
0.89
|
| Research and Development Expenses |
$20.13 M
|
$6.17 M
|
$4.27 M
|
$3.86 M
|
$1.04 M
|
$750.48 K
|
$1.16 M
|
| General & Administrative Expenses |
$14.12 M
|
$5.90 M
|
$8.55 M
|
$6.96 M
|
$6.65 M
|
$1.76 M
|
$1.10 M
|
| Selling & Marketing Expenses |
$10.26 M
|
$4.06 M
|
$2.55 M
|
$3.59 M
|
$3.57 M
|
$2.84 M
|
$2.90 M
|
| Selling, General & Administrative Expenses |
$24.38 M
|
$9.96 M
|
$11.09 M
|
$10.55 M
|
$10.22 M
|
$5.00 M
|
$4.15 M
|
| Other Expenses |
-$93.39 K
|
$1.20 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$44.42 M
|
$17.34 M
|
$15.37 M
|
$13.03 M
|
$9.76 M
|
$5.75 M
|
$5.30 M
|
| Cost And Expenses |
$48.07 M
|
$21.72 M
|
$19.60 M
|
$20.08 M
|
$14.63 M
|
$8.26 M
|
$6.60 M
|
| Interest Income |
$0.00
|
$393.00
|
$0.00
|
$8.55 K
|
$2.33 K
|
$0.00
|
$0.00
|
| Interest Expense |
$737.37 K
|
$576.75 K
|
$284.27 K
|
$299.27 K
|
$153.92 K
|
$159.47 K
|
$89.62 K
|
| Depreciation & Amortization |
$1.10 M
|
$1.51 M
|
$1.01 M
|
$1.47 M
|
$1.40 M
|
$609.55 K
|
$349.14 K
|
| EBITDA |
-$24.53 M |
$16.17 M |
$12.88 M |
$16.29 M |
$14.16 M |
$10.28 M |
$5.85 M |
| EBITDA Ratio |
-1.09
|
0.44
|
0.41
|
0.46
|
0.51
|
0.57
|
0.48
|
| Operating Income Ratio |
-1.13
|
0.41
|
0.38
|
0.39
|
0.43
|
0.54
|
0.46
|
| Total Other Income/Expenses Net |
-$837.57 K
|
-$1.23 M
|
$497.48 K
|
$890.15 K
|
$688.35 K
|
-$283.25 K
|
-$11.46 M
|
| Income Before Tax |
-$26.37 M
|
$14.09 M
|
$12.36 M
|
$14.52 M
|
$12.61 M
|
$9.58 M
|
-$5.85 M
|
| Income Before Tax Ratio |
-1.17
|
0.38
|
0.39
|
0.41
|
0.45
|
0.53
|
-0.48
|
| Income Tax Expense |
$1.17 M
|
$1.49 M
|
$1.70 M
|
$1.75 M
|
$2.42 M
|
$2.43 M
|
$1.28 M
|
| Net Income |
-$27.28 M
|
$12.45 M
|
$10.55 M
|
$12.57 M
|
$11.68 M
|
$7.10 M
|
-$7.18 M
|
| Net Income Ratio |
-1.21
|
0.34
|
0.34
|
0.36
|
0.42
|
0.39
|
-0.59
|
| EPS |
-0.98 |
0.49 |
0.41 |
0.0217 |
-0.0242 |
0.9878391652 |
-0.9995034435 |
| EPS Diluted |
-0.98 |
0.49 |
0.41 |
0.0217 |
-0.0242 |
0.9878391652 |
-0.9995034435 |
| Weighted Average Shares Out |
$27.79 M
|
$25.56 M
|
$7.58 M
|
$6.29 M
|
$7.19 M
|
$7.19 M
|
$7.19 M
|
| Weighted Average Shares Out Diluted |
$27.79 M
|
$25.63 M
|
$7.58 M
|
$7.19 M
|
$7.19 M
|
$7.19 M
|
$7.19 M
|
| Link |
|
|
|
|
|
|
|
